Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.
Victor Argaet(QIMR Berghofer Medical Research Institute), I S Misko(QIMR Berghofer Medical Research Institute), Michael G. Kurilla(QIMR Berghofer Medical Research Institute), Andreas Suhrbier(The University of Queensland), Christopher Schmidt(QIMR Berghofer Medical Research Institute), Sharon L. Silins(QIMR Berghofer Medical Research Institute), Denise L. Doolan(The University of Queensland), E Kieff(QIMR Berghofer Medical Research Institute), T B Sculley(QIMR Berghofer Medical Research Institute), Scott R. Burrows(Australian National University), Denis J. Moss(The University of Queensland)
Cited by 281
Related Papers
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391
The Complexity of Protective Immunity Against Liver-Stage Malaria
|The Journal of Immunology|2000|332
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
|Proceedings of the National Academy of Sciences|1999|332